Die Studie

Clinical trial of a new drug that has been developed for the treatment of rheumatism.

  • You are a healthy man. 
  • You are between 18 and 50 years old. 
  • Your body weight is between 60 and 100 kg and your Body Mass Index (BMI) is between 18.5 and 30.0 kg/m2.
  • You do not smoke and you do not use nicotine-containing products.


  • You cannot participate in the trial if you have participated in another clinical trial in the 3 months prior to this clinical trial (counting from the follow-up visit). This might be longer for certain trials, please contact us for more information.
  • For this trial, you cannot (have) receive(d) a COVID-19 vaccine or booster within 1 week prior to the start of this trial.
  • To determine if you are suitable to participate in this trial, you will undergo a medical screening. Depending on availability, this can be performed in Groningen or in Utrecht.

You can only participate if you meet one of the following conditions:

  • Your female partner uses a form of contraception (such as the pill or an IUD);
  • You have been sterilized or your female partner is sterilized or postmenopausal;
  • You abstain from (hetero)sexual intercourse (you are not sexually active) according to your lifestyle.


The trial consists of 1 period during which you will stay in the research facility in Groningen for 6 days (5 nights), followed by 10 short visits, including the follow-up visit.

PLEASE NOTE: You must be available for all dates to be able to participate in this study. 


You will receive a gross compensation of € 3072 for participation in one of the groups. Travelling expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per round trip, regardless of the mode of transportation.